← back to search

Pengfei Zhang

Shanghai University · CN
Area of research
Environmental Chemistry · Astronomy and Astrophysics
Research interest
Research interests include Methane Hydrates and Related Phenomena, Ionosphere and magnetosphere dynamics, Geophysics and Gravity Measurements, and Seismic Waves and Analysis.
h-index
42
citations
6,681
works
1,199
NIH funding
primary concept
email

Recent publications

Lysine‐specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti‐programmed death 1 therapy in liver cancer
Clinical and Translational Medicine 2025cited by 6position: middledoi
Global research trends on ALK-TKIs in non-small cell lung cancer: a bibliometric analysis
Frontiers in Pharmacology 2025cited by 1position: middledoi
Long‐term outcomes of ripretinib versus sunitinib in Chinese patients with advanced gastrointestinal stromal tumor: An updated analysis of a phase 2 randomized clinical trial
Cancer 2025cited by 0position: middledoi
ScRNA-seq of gastric cancer tissues reveals differences in the immune microenvironment of primary tumors and metastases
Oncogene 2024cited by 13position: middledoi
Research progress on the multi-omics and survival status of circulating tumor cells.
2024cited by 11position: contributordoi
Enhancing the differential diagnosis of small pulmonary nodules: a comprehensive model integrating plasma methylation, protein biomarkers, and LDCT imaging features
Journal of Translational Medicine 2024cited by 10position: lastdoi
CTSL, a prognostic marker of breast cancer, that promotes proliferation, migration, and invasion in cells in triple-negative breast cancer
Frontiers in Oncology 2023cited by 17position: middledoi
OA01.03 Benmelstobart with Anlotinib plus Chemotherapy as First-line Therapy for ES-SCLC: A Randomized, Double-blind, Phase III Trial
Journal of Thoracic Oncology 2023cited by 12position: middledoi
Design, Synthesis, and Acute Toxicity Assays for Novel Thymoquinone Derivative TQFL12 in Mice and the Mechanism of Resistance to Toxicity.
2023cited by 3position: contributordoi
Identification of a Difluorinated Alkoxy Sulfonyl Chloride as a Novel Antitumor Agent for Hepatocellular Carcinoma through Activating Fumarate Hydratase Activity.
2023cited by 1position: contributordoi
Tumor-derived exosomes: immune properties and clinical application in lung cancer
Cancer Drug Resistance 2022cited by 23position: lastdoi
Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway
Frontiers in Oncology 2022cited by 15position: middledoi
A novel machine learning model based on sparse structure learning with adaptive graph regularization for predicting drug side effects
Journal of Biomedical Informatics 2022cited by 13position: contributordoi
Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway
Frontiers in Oncology 2022cited by 2position: middledoi
Surfactant-assisted one-pot sample preparation for label-free single-cell proteomics.
2021cited by 94position: contributordoi
circRNA circMED27 acts as a prognostic factor and mediator to promote lenvatinib resistance of hepatocellular carcinoma
Molecular Therapy — Nucleic Acids 2021cited by 45position: firstdoi
CHIP-mediated CIB1 ubiquitination regulated epithelial-mesenchymal transition and tumor metastasis in lung adenocarcinoma.
2021cited by 18position: contributordoi
Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis.
2021cited by 16position: contributordoi
A strain of highly pathogenic porcine reproductive and respiratory syndrome virus: genomic characterization, pathogenicity, and construction of an infectious full-length cDNA clone
Archives of Virology 2021cited by 6position: middledoi
Identification of ubiquitinated substrate proteins and their gene expression patterns in lung adenocarcinoma
Annals of Translational Medicine 2021cited by 2position: middledoi
2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS
Endocrine 2020cited by 318position: middledoi
Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA
Aging 2020cited by 95position: middledoi
Thyroid imaging reporting and data system (TIRADS) for ultrasound features of nodules: multicentric retrospective study in China
Endocrine 2020cited by 59position: middledoi
lncRNA RP11-624L4.1 Is Associated with Unfavorable Prognosis and Promotes Proliferation via the CDK4/6-Cyclin D1-Rb-E2F1 Pathway in NPC.
2020cited by 26position: contributordoi
Nucleolin promotes Ang II-induced phenotypic transformation of vascular smooth muscle cells by regulating EGF and PDGF-BB.
2020cited by 13position: contributordoi
A convenient reagent for the conversion of aldoximes into nitriles and isonitriles.
2020cited by 11position: contributordoi
Carrier-assisted One-pot Sample Preparation for Targeted Proteomics Analysis of Small Numbers of Human Cells.
2020cited by 3position: contributordoi
Identification of a 3,3-difluorinated tetrahydropyridinol compound as a novel antitumor agent for hepatocellular carcinoma acting via cell cycle arrest through disturbing CDK7-mediated phosphorylation of Cdc2.
2020cited by 3position: contributordoi
Automated Nanoflow Two-Dimensional Reversed-Phase Liquid Chromatography System Enables In-Depth Proteome and Phosphoproteome Profiling of Nanoscale Samples.
2019cited by 39position: contributordoi
Carrier-Assisted Single-Tube Processing Approach for Targeted Proteomics Analysis of Low Numbers of Mammalian Cells.
2019cited by 22position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 5 papers (2020–2024)Xiaoyong Huang · Shanxi Agricultural University4 papers (2014–2025)Linyou Zhang · Harbin Medical University3 papers (2021–2022)Guo‐Ming Shi · Fudan University3 papers (2014–2025)Ai‐Wu Ke · Fudan University3 papers (2014–2025)Jiabin Cai · Sun Yat-sen University3 papers (2014–2025)Jia Fan · China Medical University2 papers (2014–2015)Yin Wu · Nanchang University2 papers (2018–2018)Shengqiang Zhang · Harbin Medical University2 papers (2022–2022)Zao‐Zhuo Shen · Fudan University2 papers (2014–2015)Wei-Jun Qian · Pacific Northwest National Laboratory2 papers (2020–2021) · 2 papers (2019–2021)Wei-Jun Qian · Pacific Northwest National Laboratory2 papers (2019–2021)Tujin Shi · Pacific Northwest National Laboratory2 papers (2019–2021)Chia-Feng Tsai · Pacific Northwest National Laboratory2 papers (2019–2021)Ronald J. Moore · Atlanta Technical College2 papers (2019–2021)Shu‐Qiang Zhu · Nanchang University2 papers (2018–2020)Xiang Long · Nanchang University2 papers (2018–2020)Richard Smith · Salisbury NHS Foundation Trust2 papers (2019–2021)Zhao‐Ru Dong · Qilu Hospital of Shandong University2 papers (2014–2015)